Patient research priority setting partnership in human T‐cell lymphotropic virus type I
Abstract Introduction Human T‐cell lymphotropic virus type 1 (HTLV‐1) is a chronic infection affecting 5–10 million people worldwide. Ten percent develop HTLV‐1‐associated diseases, and 3%–5% develop HTLV‐1‐associated myelopathy (HAM)/tropical spastic paraparesis. Low health‐related quality of life...
Main Authors: | Adine Adonis, Anne‐Marie Russell, Graham P. Taylor, Melanie Preston, Alpheus Shields, Sue Strachan, Sky Young, Haissata Diallo, Stephen Ashford, Elizabeth Cassidy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Health Expectations |
Subjects: | |
Online Access: | https://doi.org/10.1111/hex.13848 |
Similar Items
-
Patient-identified priorities for successful partnerships in patient-oriented research
by: Maria J. Santana, et al.
Published: (2022-09-01) -
What are important areas where better technology would support women’s health? Findings from a priority setting partnership
by: Sharon Dixon, et al.
Published: (2023-12-01) -
What happens after James Lind Alliance Priority Setting Partnerships? A qualitative study of contexts, processes and impacts
by: Kristina Staley, et al.
Published: (2020-07-01) -
Involving stakeholders in research priority setting: a scoping review
by: Christiane Grill
Published: (2021-10-01) -
Editorial: Prevention and control of human T lymphotropic viruses 1 and 2 (HTLV-1/2)
by: Luiz Fernando Almeida Machado, et al.
Published: (2022-08-01)